Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  12/14/2000
 
Trade Name:  TamiFlu
 
Generic Name or Proper Name (*):  oseltamivir
 
Indications Studied:  Treatment of uncomplicated acute illness due to influenza
 
Label Changes Summary:  Safety and effectiveness established for treatment in patients 1-12 years of age The safety and effectiveness in pediatric patients younger than 1 year of age have not been established Safety and effectiveness for prophylaxis in pediatric patients younger than 13 years of age have not been established (Note: labeled for prophylaxis down to 1 year due to PREA on 12/21/2005) The adverse event profile in adolescents is similar to that for adults and pediatric patients aged 1 to 12 years Information on dosing, PK parameters, AE profile, and clinical studies
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  Roche
 
Pediatric Exclusivity Granted Date:  03/22/2004
 
NNPS:  FALSE'
 
Therapeutic Category:  Antiviral
 
-
-